Business ❯ Corporate Governance ❯ Shareholder Rights ❯ Securities Regulation

uniQure N.V.

Plaintiff Firms Step Up uniQure Solicitation After FDA Rebuke, With April 13 Lead-Plaintiff Deadline

Investor solicitations intensify following an FDA official’s public dispute of uniQure’s trial design.